Trials / Withdrawn
WithdrawnNCT01171950
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients
CentriMag Ventricular Assist System (VAS): Treatment of Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 5 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help pediatric patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CentriMag Ventricular Assist System | All patients will be treated with the CentriMag device for up to 30 days. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-07-29
- Last updated
- 2022-06-24
Source: ClinicalTrials.gov record NCT01171950. Inclusion in this directory is not an endorsement.